(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.38%) $966.30
(-0.36%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
2 days till quarter result
(tns 2024-05-06)
Expected move: +/- 0.00%
-0.16% $ 0.191
Live Chart Being Loaded With Signals
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada...
Stats | |
---|---|
Объем за сегодня | 11 680.00 |
Средний объем | 3 003.00 |
Рыночная капитализация | 5.74M |
EPS | $0 ( 2024-02-12 ) |
Дата следующего отчета о доходах | ( $0 ) 2024-05-06 |
Last Dividend | $0.500 ( 2008-08-19 ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.53 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-28 | Riva Sheppard | Buy | 150 000 | Stock Option (right to buy) |
2023-11-28 | Kay Christina | Buy | 150 000 | Stock Option (right to buy) |
2023-11-28 | Masi Dina | Buy | 150 000 | Stock Option (right to buy) |
2023-03-20 | Kay E Gerald | Sell | 150 000 | Stock Option (right to buy) |
2023-03-20 | Kay E Gerald | Sell | 100 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
84.19 |
Last 98 transactions |
Buy: 38 374 999 | Sell: 953 334 |
Integrated BioPharma, Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Integrated BioPharma, Финансовые показатели
Annual | 2023 |
Выручка: | $50.67M |
Валовая прибыль: | $4.06M (8.01 %) |
EPS: | $-0.00110 |
FY | 2023 |
Выручка: | $50.67M |
Валовая прибыль: | $4.06M (8.01 %) |
EPS: | $-0.00110 |
FY | 2023 |
Выручка: | $0 |
Валовая прибыль: | $0 (0.00 %) |
EPS: | $0 |
FY | 2022 |
Выручка: | $56.25M |
Валовая прибыль: | $6.55M (11.65 %) |
EPS: | $0.130 |
Financial Reports:
No articles found.
Integrated BioPharma, Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.500 | 2008-08-19 |
Last Dividend | $0.500 | 2008-08-19 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.500 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.59 | -- |
Div. Sustainability Score | 2.86 | |
Div.Growth Potential Score | 0.996 | |
Div. Directional Score | 1.930 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
FULO | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% | |
EMYB | Ex Dividend Knight | 2023-06-29 | Annually | 0 | 0.00% | |
CBKM | Ex Dividend Knight | 2023-08-18 | Quarterly | 0 | 0.00% | |
TNCAF | Ex Dividend Junior | 2023-08-30 | Quarterly | 0 | 0.00% | |
RSKIA | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
NIPNF | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
FMCB | Ex Dividend Knight | 2023-06-08 | Semi-Annually | 0 | 0.00% | |
CSBB | Ex Dividend Knight | 2023-09-01 | Quarterly | 0 | 0.00% | |
WCRS | Ex Dividend Junior | 2023-08-21 | Quarterly | 0 | 0.00% | |
BABB | Ex Dividend King | 2023-09-27 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.00615 | 1.500 | -0.123 | -0.185 | [0 - 0.5] |
returnOnAssetsTTM | -0.0150 | 1.200 | -0.499 | -0.599 | [0 - 0.3] |
returnOnEquityTTM | -0.0205 | 1.500 | -1.339 | -2.01 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.93 | 0.800 | 0.372 | 0.298 | [1 - 3] |
quickRatioTTM | 0.765 | 0.800 | -0.203 | -0.162 | [0.8 - 2.5] |
cashRatioTTM | 0.125 | 1.500 | -0.414 | -0.621 | [0.2 - 2] |
debtRatioTTM | 0.0884 | -1.500 | 8.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -27.32 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.00942 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.00829 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.122 | -1.500 | 9.51 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0535 | 1.000 | -2.44 | -2.44 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0109 | 1.000 | -2.22 | -2.22 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.125 | 1.000 | -0.419 | -0.419 | [0.2 - 2] |
assetTurnoverTTM | 2.43 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 2.86 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -14.92 | 1.000 | -1.608 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0205 | 2.50 | -0.861 | -2.01 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.00829 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.00942 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.111 | 1.500 | -2.60 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00453 | 1.000 | -2.39 | 0 | [0.1 - 0.5] |
Total Score | 0.996 |
Integrated BioPharma,
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа